fasudil has been researched along with Hyperphagia in 1 studies
fasudil: intracellular calcium antagonist; structure in first source
fasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.
Hyperphagia: Ingestion of a greater than optimal quantity of food.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Butruille, L | 1 |
Mayeur, S | 1 |
Duparc, T | 1 |
Knauf, C | 1 |
Moitrot, E | 1 |
Fajardy, I | 1 |
Valet, P | 1 |
Storme, L | 1 |
Deruelle, P | 1 |
Lesage, J | 1 |
1 other study available for fasudil and Hyperphagia
Article | Year |
---|---|
Prenatal fasudil exposure alleviates fetal growth but programs hyperphagia and overweight in the adult male rat.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Age Factors; Animals; Female; Fetal Development; Feta | 2012 |